>15
2026
影响因子区间
251天
平台估算
26%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.Topics of particular interest within the journal's scope include, but are not limited to, those listed below:Cancer biologyImmunologyNeuroscienceCardiovascular biologyGenetics and genomicsGene therapyMetabolic diseasesStem cells and regenerative medicinePhysiology and diseasesMolecular Medicine.
【译文】实验与分子医学(EMM)是韩国第一本生物化学期刊(成立于1964年),于1996年作为开放获取、全面同行评审的国际期刊重新启动。它是一本致力于发表转化研究最新进展和生物医学领域最新发现的医学研究期刊。鼓励提交涉及人类生理学和疾病遗传、分子和细胞研究的论文。该期刊旨在突出使用特定分子工具进行的实验和转化研究对人类健康带来的改进临床效益。同时欢迎包含基础发现与临床相关性的研究以及处理明确的体内相关性和新颖性的文章。实验与分子医学是一本开放获取、仅在线的期刊。期刊特别感兴趣的主题包括但不限于以下内容:癌症生物学、免疫学、神经科学、心血管生物学、遗传学和基因组学、基因治疗、代谢性疾病、干细胞和再生医学、生理学和疾病、分子医学。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | >15 | 暂无 |